T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment

Saskia J.A.M. Santegoets, Anita G.M. Stam, Sinéad M. Lougheed, Helen Gall, Petra E.T. Scholten, Martine Reijm, Karin Jooss, Natalie Sacks, Kristen Hege, Israel Lowy, Jean Marie Cuillerot, B. Mary E. Von Blomberg, Rik J. Scheper, Alfons J.M. Van Den Eertwegh, Winald R. Gerritsen, Tanja D. De Gruijl

Research output: Contribution to journal › Article › peer-review

68 Scopus citations

Fingerprint

Dive into the research topics of 'T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences